Literature DB >> 15569735

Evaluation of cortical atrophy between progressive supranuclear palsy and corticobasal degeneration by hemispheric surface display of MR images.

Masato Taki1, Kazunari Ishii, Tetsuya Fukuda, Yoshio Kojima, Etsuro Mori.   

Abstract

BACKGROUND AND
PURPOSE: Three-dimensional imaging and hemispheric volumetry are useful for the assessment of degenerative cortical atrophy. Our purpose was to determine the features of cortical atrophy in progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) by means of a hemispheric surface display generated with MR images.
METHODS: The extent of cortical atrophy was evaluated with automated MR hemispheric surface display and volumetry in 19 patients with PSP and 19 with CBD.
RESULTS: Most cortical regions were less atrophic in PSP than in CBD. The parietal lobe, paracentral regions, anterior middle frontal lobe, and posterior inferior frontal lobe were significantly more atrophic in CBD than in PSP, whereas the brainstem was significantly more atrophic in PSP. The mean hemisphere-to-intracranial volume ratio was significantly greater in patients with PSP (74.5%) than in those with CBD (71.4%), whereas the mean brainstem-to-intracranial volume ratio was significantly smaller in PSP (1.4%) than in CBD (1.6%). Asymmetry of hemispheric volume was significantly larger in the CBD group than in the PSP group.
CONCLUSION: Hemispheric surface display and volumetry are generally helpful and especially useful for the differentiation of PSP and CBD.

Entities:  

Mesh:

Year:  2004        PMID: 15569735      PMCID: PMC8148711     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  27 in total

1.  Corticobasal degeneration.

Authors:  W R Gibb; P J Luthert; C D Marsden
Journal:  Brain       Date:  1989-10       Impact factor: 13.501

Review 2.  Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop.

Authors:  I Litvan; Y Agid; D Calne; G Campbell; B Dubois; R C Duvoisin; C G Goetz; L I Golbe; J Grafman; J H Growdon; M Hallett; J Jankovic; N P Quinn; E Tolosa; D S Zee
Journal:  Neurology       Date:  1996-07       Impact factor: 9.910

3.  Distribution of cerebral cortical lesions in corticobasal degeneration: a clinicopathological study of five autopsy cases in Japan.

Authors:  K Tsuchiya; K Ikeda; T Uchihara; T Oda; H Shimada
Journal:  Acta Neuropathol       Date:  1997-11       Impact factor: 17.088

4.  MRI in corticobasal degeneration.

Authors:  M Grisoli; V Fetoni; M Savoiardo; F Girotti; M G Bruzzone
Journal:  Eur J Neurol       Date:  1995-12       Impact factor: 6.089

5.  Medial temporal and whole-brain atrophy in dementia with Lewy bodies: a volumetric MRI study.

Authors:  M Hashimoto; H Kitagaki; T Imamura; N Hirono; T Shimomura; H Kazui; S Tanimukai; T Hanihara; E Mori
Journal:  Neurology       Date:  1998-08       Impact factor: 9.910

6.  Progressive supranuclear palsy: MRI and pathological findings.

Authors:  A Yagishita; M Oda
Journal:  Neuroradiology       Date:  1996-05       Impact factor: 2.804

7.  Corticobasal degeneration: etiopathological significance of the cytoskeletal alterations.

Authors:  K Wakabayashi; K Oyanagi; T Makifuchi; F Ikuta; A Homma; Y Homma; Y Horikawa; S Tokiguchi
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

Review 8.  Differential diagnosis of Parkinson's disease and atypical parkinsonian disorders by magnetic resonance imaging.

Authors:  M Savoiardo
Journal:  Neurol Sci       Date:  2003-05       Impact factor: 3.307

9.  Cerebral blood flow in corticobasal degeneration and progressive supranuclear palsy.

Authors:  B Okuda; H Tachibana; K Kawabata; M Takeda; M Sugita
Journal:  Alzheimer Dis Assoc Disord       Date:  2000 Jan-Mar       Impact factor: 2.703

10.  Corticobasal degeneration shares a common genetic background with progressive supranuclear palsy.

Authors:  E Di Maria; M Tabaton; T Vigo; G Abbruzzese; E Bellone; C Donati; E Frasson; R Marchese; P Montagna; D G Munoz; P P Pramstaller; G Zanusso; F Ajmar; P Mandich
Journal:  Ann Neurol       Date:  2000-03       Impact factor: 10.422

View more
  5 in total

Review 1.  Other dementias.

Authors:  Gaida Krumina
Journal:  Neuroradiology       Date:  2011-09       Impact factor: 2.804

Review 2.  Neuroimaging of rapidly progressive dementias, part 1: neurodegenerative etiologies.

Authors:  A J Degnan; L M Levy
Journal:  AJNR Am J Neuroradiol       Date:  2013-02-22       Impact factor: 3.825

3.  Asymmetrical cerebral perfusion demonstrated by noninvasive arterial spin-labeling perfusion imaging in a patient with corticobasal degeneration.

Authors:  Tuvshinjargal Dashjamts; Takashi Yoshiura; Akio Hiwatashi; Koji Yamashita; Koichiro Abe; Yasumasa Ohyagi; Junichi Kira; Hiroshi Honda
Journal:  Jpn J Radiol       Date:  2010-01-30       Impact factor: 2.374

Review 4.  Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be?

Authors:  Jennifer L Whitwell; Günter U Höglinger; Angelo Antonini; Yvette Bordelon; Adam L Boxer; Carlo Colosimo; Thilo van Eimeren; Lawrence I Golbe; Jan Kassubek; Carolin Kurz; Irene Litvan; Alexander Pantelyat; Gil Rabinovici; Gesine Respondek; Axel Rominger; James B Rowe; Maria Stamelou; Keith A Josephs
Journal:  Mov Disord       Date:  2017-05-13       Impact factor: 10.338

5.  Brain alterations and mini-mental state examination in patients with progressive supranuclear palsy: voxel-based investigations using f-fluorodeoxyglucose positron emission tomography and magnetic resonance imaging.

Authors:  Ryuichi Takahashi; Kazunari Ishii; Tatsuya Kakigi; Kazumasa Yokoyama; Etsuro Mori; Takamichi Murakami
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2011-11-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.